DNA

6.80

6.25% 0.40

Dopo l'orario di chiusura: 6.81 0.010 +0.15%

Ginkgo Bioworks Holdings Inc (DNA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché DNA Giù? Forum Previsione

Precedente Chiudi:

$6.40

Aprire:

$6.43

Volume 24 ore:

1.75M

Relative Volume:

1.60

Capitalizzazione di mercato:

$421.09M

Reddito:

$217.11M

Utile/perdita netta:

$-651.19M

Rapporto P/E:

-0.5235

EPS:

-12.99

Flusso di cassa netto:

$-387.26M

1 W Prestazione:

+4.62%

1M Prestazione:

-26.80%

6M Prestazione:

-32.07%

1 anno Prestazione:

+5.26%

Intervallo 1D:

$6.43

$7.06

Intervallo di 1 settimana:

$6.26

$7.06

Portata 52W:

$5.00

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Nome

Ginkgo Bioworks Holdings Inc

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

(877) 442-5362

Indirizzo

27 DRYDOCK AVENUE, BOSTON

Dipendente

485

Cinguettio

Prossima data di guadagno

2024-08-08

Ultimi documenti SEC

DNA's Discussions on Twitter

Compare DNA vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DNA Ginkgo Bioworks Holdings Inc	6.80	421.09M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	469.34	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.51B	5.36B	287.73M	924.18M	2.5229

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-15	Downgrade	BTIG Research	Neutral → Sell
2024-05-10	Downgrade	William Blair	Mkt Perform → Underperform
2023-11-14	Downgrade	Raymond James	Outperform → Mkt Perform
2023-11-09	Downgrade	BTIG Research	Buy → Neutral
2023-06-02	Downgrade	Goldman	Neutral → Sell
2023-05-11	Downgrade	William Blair	Outperform → Mkt Perform
2022-11-29	Iniziato	Berenberg	Buy
2022-10-04	Iniziato	Morgan Stanley	Equal-Weight
2022-05-18	Downgrade	BofA Securities	Neutral → Underperform
2022-03-02	Ripresa	Cowen	Outperform
2022-02-23	Iniziato	Goldman	Neutral
2022-02-01	Iniziato	BofA Securities	Neutral
2022-01-28	Iniziato	BofA Securities	Buy
2022-01-07	Iniziato	BTIG Research	Buy
2021-11-29	Iniziato	Jefferies	Buy
2021-10-13	Iniziato	Raymond James	Outperform
2021-10-12	Iniziato	William Blair	Outperform
2021-09-20	Iniziato	HSBC Securities	Buy

Mostra tutto

Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie

12:08 PM

How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance

12:08 PM

Mar 13, 2026

Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 - Benzinga

Mar 13, 2026

(DNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Mar 13, 2026

Mar 12, 2026

Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $5.00 by Analysts at BTIG Research - MarketBeat

Mar 12, 2026

Ginkgo Bioworks price target lowered to $5 from $9 at BTIG - TipRanks

Mar 12, 2026

BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift - Investing.com

Mar 12, 2026